tiprankstipranks
Nascent Biotech Inc. (NBIO)
OTHER OTC:NBIO
US Market

Nascent Biotech (NBIO) Financial Statements

33 Followers

Nascent Biotech Financial Overview

Nascent Biotech's market cap is currently ―. The company's EPS TTM is $-0.014; its P/E ratio is -5.75; Nascent Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-$ 136.51K---
EBIT$ -642.51K$ 35.39K$ -2.42M$ -188.42K$ 376.89K
EBITDA-$ 267.77K$ -2.04M$ 438.61K$ 376.89K
Net Income Common Stockholders$ -767.63K$ -540.22K$ -2.99M$ -837.32K$ -145.71K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 9.48K$ 172.19K$ 558.76K$ 1.18M
Total Assets$ 1.04M$ 78.92K$ 255.00K$ 565.84K$ 1.20M
Total Debt$ 305.00K$ 276.97K$ 389.59K$ 470.17K$ 293.14K
Net Debt$ 305.00K$ 267.49K$ 217.41K$ -88.59K$ -888.77K
Total Liabilities$ 1.05M$ 1.23M$ 1.55M$ 1.93M$ 2.39M
Stockholders Equity$ -6.41K$ -1.16M$ -1.30M$ -1.36M$ -1.19M
Cash Flow-
Free Cash Flow-$ -162.71K$ -386.58K$ -623.15K$ -433.66K
Operating Cash Flow$ -341.51K$ -162.71K$ -386.58K$ -623.15K$ -433.66K
Investing Cash Flow-----
Financing Cash Flow$ 1.34M---$ 1.47M
Currency in USD

Nascent Biotech Earnings and Revenue History

Nascent Biotech Debt to Assets

Nascent Biotech Cash Flow

Nascent Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis